Alison Douglas is a skilled Clinical Analyst, Biomedical Engineer, and Research Scientist who has spent the past 8 years developing therapies and cutting-edge technologies to improve patient outcomes. With a PhD in Biomedical Engineering from a joint program offered by Georgia Institute of Technology and Emory University, she is well-versed in data analysis and interpretation, has excellent communication skills and is able to lead multi-disciplinary teams.

Her expertise lies in cardiovascular research, including hemostasis, fibrin sealants, stem cells, tissue engineering, biomaterials, wound healing, and regenerative medicine, as well as oncology. Douglas has held several research positions, most recently as a Clinical Scientist at Sarah Cannon and previously as a Research Scientist at Cresilon, Inc. (formerly Suneris) and an IGERT Stem Cell Biomanufacturing Trainee at National Science Foundation (NSF).

She has also worked as a Predoctoral Fellow at American Heart Association - American Stroke Association, a Graduate Research Assistant at Georgia Institute of Technology, an Undergraduate Research Assistant at Tulane University, and an REU at Vanderbilt University.

Overall, Alison Douglas is a highly skilled professional with a passion for finding innovative solutions to complex problems in the biomedical field.